Takeshi Nabe Selected Research

Nasal Obstruction

11/2015	Longitudinal study of effects of oral dosage of Bifidobacterium bifidum G9-1 on Japanese cedar pollen-induced allergic nasal symptoms in guinea pigs.
3/2012	Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis.
8/2011	Inhibition of hematopoietic prostaglandin D synthase improves allergic nasal blockage in guinea pigs.
6/2009	Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
1/2009	Effect of TA-270, a novel quinolinone derivative, on antigen-induced nasal blockage in a guinea pig model of allergic rhinitis.
12/2008	Effect of local nasal immunotherapy on nasal blockage in pollen-induced allergic rhinitis of Guinea pigs.
3/2008	Involvement of peroxynitrite in pollen-induced nasal blockage in guinea pigs.
11/2007	Polycyclic aromatic hydrocarbons aggravate antigen-induced nasal blockage in experimental allergic rhinitis.
11/2007	Nasal blockage induced by oral administration of non-steroidal anti-inflammatory drugs in a guinea-pig model of allergic rhinitis.
9/2006	Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Nabe Research Topics

Disease

24	Asthma (Bronchial Asthma) 09/2022 - 01/2010
19	Inflammation (Inflammations) 02/2022 - 11/2007
16	Nasal Obstruction 11/2015 - 03/2002
14	Allergic Rhinitis 11/2015 - 03/2002
9	Respiratory Hypersensitivity 09/2022 - 09/2009
9	Atopic Dermatitis (Atopic Eczema) 01/2019 - 06/2009
8	Airway Remodeling 09/2022 - 01/2011
8	Sneezing 06/2009 - 03/2002
7	Hyperplasia 01/2015 - 03/2008
6	Eosinophilia 02/2022 - 03/2002
6	Pruritus (Itching) 01/2019 - 08/2003
5	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 03/2017 - 12/2003
4	Conjunctivitis 03/2017 - 12/2003
3	Fibrosis (Cirrhosis) 01/2015 - 01/2012
2	Dermatitis 02/2015 - 04/2013
2	Airway Obstruction (Choking) 02/2014 - 09/2009
2	Pulmonary Emphysema 01/2010 - 09/2009
1	Experimental Arthritis 06/2021
1	Neoplasms (Cancer) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Skin Diseases (Skin Disease) 12/2015

Drug/Important Bio-Agent (IBA)

27	AntigensIBA 02/2022 - 03/2002
12	Immunoglobulin E (IgE)IBA 12/2015 - 08/2005
7	CytokinesIBA 02/2022 - 02/2012
7	AllergensIBA 12/2015 - 08/2003
6	Histamine (Histamine Dihydrochloride)FDA Link 10/2018 - 03/2002
6	Interleukin-33IBA 01/2018 - 06/2013
6	InterleukinsIBA 01/2018 - 01/2011
5	Monoclonal AntibodiesIBA 02/2022 - 01/2012
5	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2012
4	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022 - 03/2008
4	GlucocorticoidsIBA 01/2020 - 01/2014
4	Leukotriene D4IBA 01/2017 - 08/2003
4	pranlukastIBA 01/2010 - 12/2003
4	LeukotrienesIBA 12/2008 - 10/2004
3	SteroidsIBA 09/2022 - 01/2020
3	Interleukin-10 (Interleukin 10)IBA 09/2022 - 02/2012
3	Methacholine Chloride (Methacholine)FDA Link 12/2019 - 09/2009
3	Interleukin-5 (Interleukin 5)IBA 12/2019 - 03/2002
3	Ethanol (Ethyl Alcohol)IBA 01/2019 - 06/2009
3	cysteinyl leukotriene receptor 2IBA 01/2018 - 10/2015
3	Immunoglobulin G (IgG)IBA 03/2017 - 01/2012
3	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2017 - 11/2007
3	Arachidonic Acid (Vitamin F)IBA 04/2013 - 08/2004
3	Peroxynitrous Acid (Peroxynitrite)IBA 01/2013 - 03/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2008 - 12/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022 - 03/2008
2	CeramidesIBA 01/2021 - 01/2018
2	montelukast (Singulair)FDA Link 01/2017 - 10/2015
2	gemilukastIBA 10/2015 - 08/2015
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2015 - 04/2013
2	CXC ChemokinesIBA 02/2014 - 02/2012
2	Pharmaceutical PreparationsIBA 08/2013 - 03/2012
2	Ketotifen (Ketotifene)FDA Link 08/2013 - 08/2003
2	LipopolysaccharidesIBA 01/2010 - 09/2009
2	SmokeIBA 01/2010 - 09/2009
2	SolutionsIBA 01/2010 - 09/2009
2	Theophylline (Theon)FDA LinkGeneric 01/2010 - 09/2009
2	Indicators and Reagents (Reagents)IBA 06/2009 - 12/2008
2	ThromboxanesIBA 09/2006 - 10/2004
2	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 09/2006 - 10/2004
2	icatibantIBA 08/2003 - 08/2003
2	Bradykinin B1 ReceptorIBA 08/2003 - 08/2003
2	BradykininIBA 08/2003 - 08/2003
1	Interleukin-10 ReceptorsIBA 09/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2022
1	EndotoxinsIBA 06/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2021
1	dihydroceramide desaturaseIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SphingolipidsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	OvalbuminIBA 12/2019
1	Pregnanolone (Allopregnanolone)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	NeurosteroidsIBA 01/2019
1	Calcium Channels (Calcium Channel)IBA 10/2018
1	Hypnotics and Sedatives (Sedatives)IBA 10/2018
1	AMPA Receptors (AMPA Receptor)IBA 10/2018
1	BarbituratesIBA 10/2018
1	barbituric acid (barbiturate)IBA 10/2018
1	eicosapentaenoic acid ethyl esterIBA 01/2018
1	PapainIBA 03/2017
1	Immunoglobulin Fab FragmentsIBA 03/2017
1	EpitopesIBA 03/2017
1	Guanosine Triphosphate (GTP)IBA 01/2017
1	Leukotriene C4IBA 01/2017
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017
1	Thymic Stromal LymphopoietinIBA 12/2015
1	Semaphorins (Semaphorin)IBA 10/2015
1	Linoleic Acid (Linoleate)IBA 02/2015
1	Starch (Cornstarch)IBA 02/2015

Therapy/Procedure

6	Therapeutics 09/2022 - 08/2005
5	Drug Therapy (Chemotherapy) 01/2018 - 02/2012
4	Immunotherapy 01/2019 - 08/2005
4	Oral Administration 01/2018 - 08/2003